United States · Funded startup

Who invested in Mustang Bio

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$8.0Mraised across 1 round since 2025, from 1 source

Latest round
Round, $8.0MFeb 2025
Investors
1
See who backed them

The rounds

  1. Feb 2025
    Round$8.0M

    Source recorded

Founders and team

From the SEC filings it signed: 2 on the team.

  • Manuel B. LitchmanPresident and Chief Executive Officeri
  • James B MurphyInterim Chief Financial Officeri

On the board, as filediAdam J. ChillLindsay A. RosenwaldMichael J. ZelefskyMichael S. WeissNeil A. Herskowitz

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Mustang Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Horizon Technology FinanceVenture debtPer its own site
Runway Growth CapitalPrivate creditPer its own site

Quick answers about Mustang Bio

Who invested in Mustang Bio?

Mustang Bio's investors include National Institutes of Health.

How much has Mustang Bio raised?

Mustang Bio has raised $8.0M across 1 round since 2025.

When did Mustang Bio last raise?

Mustang Bio's most recent round was an Undisclosed round of $8.0M in Feb 2025.

What was Mustang Bio's biggest round?

Its most recent round, $8.0M in Feb 2025, is also its largest on record.

Who backed Mustang Bio first?

Mustang Bio's first round on record, in Feb 2025, was backed by National Institutes of Health.

What stage is Mustang Bio at?

Mustang Bio's latest named round is an Undisclosed round, in Feb 2025.

Where is Mustang Bio based?

Mustang Bio is based in the United States.

Companies like Mustang Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.